BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 15197767)

  • 1. Suppression of tumor growth and metastasis by a VEGFR-1 antagonizing peptide identified from a phage display library.
    An P; Lei H; Zhang J; Song S; He L; Jin G; Liu X; Wu J; Meng L; Liu M; Shou C
    Int J Cancer; 2004 Aug; 111(2):165-73. PubMed ID: 15197767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered Phage-Based Cancer Vaccines: Current Advances and Future Directions.
    Ragothaman M; Yoo SY
    Vaccines (Basel); 2023 Apr; 11(5):. PubMed ID: 37243023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered M13 phage as a novel therapeutic bionanomaterial for clinical applications: From tissue regeneration to cancer therapy.
    Chang C; Guo W; Yu X; Guo C; Zhou N; Guo X; Huang RL; Li Q; Zhu Y
    Mater Today Bio; 2023 Jun; 20():100612. PubMed ID: 37063776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Fibromodulin Antagonist Peptide RP4 Exerts Antitumor Effects on Colorectal Cancer.
    Deng T; Hou Y; Lin G; Feng C; Liu K; Chen W; Wei W; Huang L; Dai X
    Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-angiogenic peptides application in cancer therapy; a review.
    Shoari A; Khodabakhsh F; Ahangari Cohan R; Salimian M; Karami E
    Res Pharm Sci; 2021 Dec; 16(6):559-574. PubMed ID: 34760005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phage-Displayed Peptides for Targeting Tyrosine Kinase Membrane Receptors in Cancer Therapy.
    Aloisio A; Nisticò N; Mimmi S; Maisano D; Vecchio E; Fiume G; Iaccino E; Quinto I
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33918836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand-Targeted Delivery of Photosensitizers for Cancer Treatment.
    Gierlich P; Mata AI; Donohoe C; Brito RMM; Senge MO; Gomes-da-Silva LC
    Molecules; 2020 Nov; 25(22):. PubMed ID: 33202648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The biologically functional identification of a novel TIM3-binding peptide P26 in vitro and in vivo.
    Zhong T; Zhao C; Wang S; Tao D; Ma S; Shou C
    Cancer Chemother Pharmacol; 2020 Dec; 86(6):783-792. PubMed ID: 33084973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of non-proteinogenic amino acids in the discovery and development of peptide therapeutics.
    Ding Y; Ting JP; Liu J; Al-Azzam S; Pandya P; Afshar S
    Amino Acids; 2020 Sep; 52(9):1207-1226. PubMed ID: 32945974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Tumor Endothelial Cells with Nanoparticles.
    Sakurai Y; Akita H; Harashima H
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31756900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vivo Translation of Peptide-Targeted Drug Delivery Systems Discovered by Phage Display.
    Newman MR; Benoit DSW
    Bioconjug Chem; 2018 Jul; 29(7):2161-2169. PubMed ID: 29889510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a novel albumin-based and maleimidopropionic acid-conjugated peptide with prolonged half-life and increased
    Feng J; Zhao C; Wang L; Qu L; Zhu H; Yang Z; An G; Tian H; Shou C
    Theranostics; 2018; 8(8):2094-2106. PubMed ID: 29721065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth receptor 1 acts as a stress-associated protein in the therapeutic response to thalidomide.
    Liu Q; Yin T; Wang G; Guo F; Ou Y; Li Y; Wang Y
    Exp Ther Med; 2017 Nov; 14(5):4263-4271. PubMed ID: 29075340
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Zhu H; Zhao C; Liu F; Wang L; Feng J; Shou C; Yang Z
    ACS Med Chem Lett; 2017 Feb; 8(2):266-269. PubMed ID: 28197324
    [No Abstract]   [Full Text] [Related]  

  • 15. Radiolabeling and evaluation of (64)Cu-DOTA-F56 peptide targeting vascular endothelial growth factor receptor 1 in the molecular imaging of gastric cancer.
    Zhu H; Zhao C; Liu F; Wang L; Feng J; Zhou Z; Qu L; Shou C; Yang Z
    Am J Cancer Res; 2015; 5(11):3301-10. PubMed ID: 26807312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advancement and applications of peptide phage display technology in biomedical science.
    Wu CH; Liu IJ; Lu RM; Wu HC
    J Biomed Sci; 2016 Jan; 23():8. PubMed ID: 26786672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A VEGFR1 antagonistic peptide inhibits tumor growth and metastasis through VEGFR1-PI3K-AKT signaling pathway inhibition.
    Zhou Z; Zhao C; Wang L; Cao X; Li J; Huang R; Lao Q; Yu H; Li Y; Du H; Qu L; Shou C
    Am J Cancer Res; 2015; 5(10):3149-61. PubMed ID: 26693066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinogen-derived fibrinostatin inhibits tumor growth through anti-angiogenesis.
    Zhao C; Su Y; Zhang J; Feng Q; Qu L; Wang L; Liu C; Jiang B; Meng L; Shou C
    Cancer Sci; 2015 Nov; 106(11):1596-606. PubMed ID: 26300396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer and embryo expression protein 65 promotes cancer cell growth and metastasis.
    Jin G; Peng L; Zhang J; Qu L; Shou C
    Oncol Lett; 2015 Apr; 9(4):1772-1778. PubMed ID: 25789040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification of a Pd20-TNFα fusion protein that prevents liver metastasis of gastric cancer.
    Hu SJ; Jiang RX; Xie HH; Ma AL; Shi HL; Shen H; Hao ZM
    Tumour Biol; 2014 Aug; 35(8):7523-9. PubMed ID: 24789430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.